Visceral leishmaniasis unresponsive to antimonial drugs ii response to high dosage sodium stibogluconate or prolonged treatment with pentamidine

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 79, Issue 5, 1985, Pages 705-714

  Bryceson, A D M ^a,f   Chulay, J D ^a,b,g   Mugambi, M ^a,c   Were, J B ^a   Gachihi, G ^a   Chunge, C N ^a   Muigai, R ^a   Bhatt, S M ^a   Ho, M ^h   Spencer, H C ^a,d   Meme, J ^e   Anabwan, G ^e  

^a Kenya MePica Research Institute ^*  (Kenya)

^b US Army Medical Research Unit Kenya   (Kenya)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d University of Nairobi ^*  (United States)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^g WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^h MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PENTAMIDINE; STIBOGLUCONATE SODIUM;

ADVERSE DRUG REACTION; ANEMIA; ANOREXIA; CARDIOTOXICITY; CLINICAL ARTICLE; DIAGNOSIS; DIGESTIVE SYSTEM; DRUG DOSE; DRUG EFFICACY; DRUG RESISTANCE; DRUG THERAPY; ELECTROCARDIOGRAPHY; HEART; HEART ARRHYTHMIA; HEPATITIS; HUMAN; INTOXICATION; KIDNEY; LETHARGY; LIVER; LIVER TOXICITY; NEPHRITIS; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PROTOZOON; SKIN ABSCESS; THERAPY; VOMITING;

AMIDINES; ANTIMONY SODIUM GLUCONATE; CHILD; DRUG RESISTANCE; FEMALE; GLUCONATES; HUMANS; LEISHMANIASIS, VISCERAL; MALE; NEPHRITIS; PENTAMIDINE; SPLEEN;

PROTOZOA;

EID: 0022242790     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/0035-9203(85)90199-3     Document Type: Article

References (21)

1. Anabwam, U. M., Nigra, J. A. (1983). Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet, i, 210-213.
2. Bryceson, A. D. M. (1970). Diffuse cutaneous leishmaniasis. II. Treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 64, 369-379.
3. Bryceson, A. D. M. (1985). Therapy in man. The Leishmaniases in Biology and Medicine. Killick-Kendrick, R. &And Peters, W. (Editors). London and New York: Academic Press (in press).
4. Bryceson, A. D. M. &And Woodstock, L. (1969). The cumulative effect of pentamidine dimethanesulphonate on the blood sugar. East African Medical Journal, 46, 170-173.
5. Bryceson, A. D. M., Chulay, J. D., Ho, M. T., Were, J. B., Muigai, R., Chunge, C., Gachihi, G., Meme, J., Anabwani, G., Bhatt, S. M. (1985). Visceral leishmaniasis unresponsive to antimonial drugs I: Clinical and immunological studies. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 700-704.
6. Chulay, J. D. &And Bryceson, A. D. M. (1983). Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 32, 475-479.
7. Chulay, J. D., Anzeze, E. M., Koech, D. K. &And Bryceson, A. D. M. (1983a). High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 77, 717-721.
8. Chulay, J. D., Bhatt, S. M., Muigai, R., Ho, M., Gachihi, G., Were, J. B. O., Chunge, C. &And Bryceson, A. D. M. (1983b). A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Journal of Infectious Diseases, 148, 148-155.
9. Chulay, J. D., Spencer, H. C. &And Mugambi, M. (1985). Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). American Journal of Tropical Medicine and Hygiene (in press).
10. Chunge, C. N., Gachihi, G., Muigai, R., Wasunna, K., Rashid, J. R., Chulay, J. D., Anabwani, G., Oster, C. N. &And Bryceson, A. D. M. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 715-718.
11. Ercoli, N. (1966). Drug responsiveness in experimental cutaneous leishmaniasis. Experimental Parasitology, 19, 141-147.
12. Ho, M., Koech, D. K., Iha, D. W. &And Bryceson, A. D. M. (1983). Immunosuppression in Kenya visceral leishmaniasis. Clinical and Experimental Immunology, 51, 207-214.
13. Kager, P. A., Rees, P. H., Wellde, B. T., Hockmeyer, W. T. &And Lyerly, W. H. (1981). Allopurinol in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 556-559.
14. Launoy, L., Guillot, M. &And Jonchere, H. (1960). Etude du stockage et l’elimination de la pentamidine chez la souris et le rat blanc. Annales Pharmaceutiques Frangaises, 18, 223-284.
15. Manson-Bahr, P. E. C. &And Heisch, R. B. (1956). Studies in leishmaniasis in East Africa. III. Clinical features and treatment. Transactions of the Royal Society of Tropical Medicien and Hygiene, 50, 465-471.
16. Rees, P. H., Keating, M. I., Kager, P. A. &And Hockmeyer, W. T. (1980). Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet, ii, 226-229.
17. Steck, E. A. (1974). The Leishmaniases. In: Progress in Drug Research. Jucker, E. (Editor). Basel and Stuttgart: Birkhauser Verlag, pp. 289-351.
18. Tuckman, E. (1949). Treatment of Chinese kala-azar with sodium antimony gluconate. Journal of Tropical Medicien and Hygiene, 52, 199-204.
19. Wijers, D. J. B. (1971). A ten years’ study of kala-azar in Tharaka (Meru District, Kenya). II: Relapses. East African Medical Journal, 48, 551-558.
20. World Health Organization (1979). Report of the workshop on the chemotherapy of mucocutaneous leishmaniasis. TDR/LEISH/79.3. Geneva: World Health Organization.
21. World Health Orgnization (1982). Report of the informal meeting on the chemotherapy of visceral leishmaniasis. TDR/CHEMLEISH/VL/82.3. Geneva: World Health Organization.